Find a TenderAwarded without competition
Published 15 Feb 2024, 09:52 GMT

Official UK procurement notice

Novosorb Biodegradable Temporizing Matrix (BTM)

Official notice

Authority: The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Central government)

GoodsAward procedure without prior publication of a call for competition
Awarded value£200,000published contract · exc. VAT
Awarded 14 Feb 2024no call for competition
Awarded to MOVIANTO UK LIMITED

What is being bought

Published requirement description

Novosorb Biodegradable Temporizing Matrix (BTM)

CPV: Dressings

The lotProcurement structure

single lot · no lot value published
Lot #1Novosorb Biodegradable Temporizing Matrix (BTM) Additional information: Supply of…

Novosorb Biodegradable Temporizing Matrix (BTM) Additional information: Supply of Novosorb Biodegradable Temporizing Matrix (BTM) via consignment agreement from Polynovo, but delivered by distributor Movianto

Delivery: North East · The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital

Procedure terms & legal framework

From the official record
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0025 Utilities Contracts Regulations 2016 (Directive 2014/25/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
15 Feb 2024, 09:52 GMT
Last source update
15 Feb 2024, 09:52 GMT
Authority reference
C247669
FTS notice number
2024/S 000-005028
Classification (CPV)
Dressings
Delivery area
North East (UKC22)
Official registry OCID
ocds-h6vhtk-043a4b Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

Polynovo is the only supplier of this product and this is the only synthetic dermal template available worldwide. The advantage above other dermal matrices, such as Integra, is that this product is very resistant to infection. Therefore low risk of it getting infected and needing removal. I have not lost a single piece of BTM from infection. <br/><br/>The clinical advantage for burns patients is earlier engagement in physiotherapy, less pain (and painkillers) and better long term scar quality. If the scars are better longterm, they need less scar therapy, less reconstruction and have better quality of life. Other teams are using this for complex wound reconstruction as an alternative to free flap surgery, which can take up to 12 hours. This takes significantly less time to apply, saving theatre time and allowing patients to be discharged earlier from hospital, with less invasive surgery.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £200,0001 contract exc. VAT
Contracts signed 1latest 14 Feb 2024
Awarded toValueDateStatus
MOVIANTO UK LIMITED£200,000 †—Awarded

Contracts

Contracting authority & participating public bodies

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Contracting authorityCentral GovernmentNovosorb Biodegradable Temporizing Matrix (BTM) for use in Healthcare Regent Point, NEWCASTLE UPON TYNE, North East, NE7 7DNContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.